Vivimed Labs Ltd. benchmarking: Perfomance to industry peers

Financial

	Vivimed Labs	Biofil Chem & Pharma	Murae Organisor
Operational Metrics
Pharmaceuticals
US DMF Filings	150.0 .	n/a	n/a
R&D as a % of Total Sales	0.14 %	n/a	n/a
Financials
5 yr Average ROE	10.89 %	4.39 %	5.64 %
5yr average Equity Multiplier	-33.72	2.06	2.09
5yr Average Asset Turnover Ratio	0.27	0.95	0.81
5yr Avg Net Profit Margin	-54.08 %	2.38 %	5.31 %
Price to Book	0.0	2.77	0.24
P/E	0.0	20.61	3.36
5yr Avg Cash Conversion Cycle	184.52 Days	75.63 Days	16.76 Days
Inventory Days	244.76 Days	28.27 Days	424.86 Days
Days Receivable	246.32 Days	389.8 Days	56.13 Days
Days Payable	159.64 Days	203.89 Days	12.67 Days
5yr Average Interest Coverage Ratio	-6.61	23.53	538.35
5yr Avg ROCE	-13.87 %	6.37 %	8.92 %
5yr Avg Operating Profit Margin	-26.56 %	3.78 %	-8.27 %
5 yr average Debt to Equity	-13.68	0.03	0.56
5yr CAGR Net Profit	-14.97 %	-14.7 %	142.32 %
5yr Average Return on Assets	-10.44 %	2.37 %	3.23 %
Shareholdings
Promoter Holding	7.77 %	46.79 %	0.0
Share Pledged by Promoters	14.8 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-13.19 %	-0.03 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Vivimed Labs	Biofil Chem & Pharma	Murae Organisor
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Speciality Chemicals 0 Chemicals Div 0 Pharma Div 0 Trading in Agriculture activities 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Pharmaceuticals 89.69 Chemicals 10.31 Speciality Chemicals 0 Pharmaceutical 0 Trading in Agriculture activities 0	Product Wise Break-Up Pharmaceuticals 0 Pharma Div 0 Chemicals Div 0 Speciality Chemicals 0 Pharmaceutical 0 Trading in Agriculture activities 100.0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 70.0 India 30.0	-	-
Operating Profit Break-Up	Operating Profit Break-Up Specialty Chemicals 100.0 Pharma 0 Chemicals Div 0 Pharma Div 0	Operating Profit Break-Up Pharmaceuticals 94.01 Pharma 0 Chemicals 5.99 Specialty Chemicals 0	-
Capex	Capex Pharma 88.18 Specialty Chemicals 11.82	-	-
Asset Break-Up	Asset Break-Up Pharma 91.29 Specialty Chemicals 8.71	-	-